Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Capital/Financing Update 2013

Apr 10, 2013

65122_rns_2013-04-10_53876e1c-88c9-428b-aa06-556207e4066d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Level 7, 15 1 Macquarie Street Sydney NSW 2000 Australia

==> picture [40 x 34] intentionally omitted <==

==> picture [135 x 34] intentionally omitted <==

11 April 2013

ASX Market Announcements ASX Limited Level 4, Exchange Centre 20 Bridge Street SYDNEY NSW 2000

Dear Sir/Madam

Share Purchase Plan – notice under ASIC CO 09/425

Prima BioMed Ltd (ASX: PR R ) ( Prima ) gives notice that within 24 hour s it will make offers to issue shares under a share p urchase plan without disclosure to investors under Part 6D.2 of the Corporations Act 2001 (C t h) ( Corporations Act ).

This notice is being given u n der Australian Securities and Investments Commission Class Order 09/425, titled 'Share an d interest purchase plans'.

At the date of this notice, P r ima has complied with the provisions of C hapter 2M of the Corporations Act as they appl y to Prima and section 674 of the Corporatio n s Act.

There is no information th a t is excluded information as at the date of this notice (in accordance with the require m ents of subsections 708A(7) and (8) of the C orporations Act as if this notice were a notice un d er paragraph 708A(5)(e) of the Corporation s Act).

Yours sincerely

==> picture [102 x 39] intentionally omitted <==

Deanne Miller General Counsel & Company Secretary